Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound ...
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private investor ...
ST. PETERSBURG, Fla., April 16 /PRNewswire-FirstCall/ -- The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI – leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI - leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results